Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant myopathy, clinically characterized by asymmetric weakness of muscles in the face, shoulder girdle and upper arm. Deletion of an integral number of 3.3 kb repeated units within a highly polymorphic EcoRI fragment at chromosome 4q35, generating a relatively short EcoRI fragment (<35 kb), has been shown to cause FSHD1. Probe p13E-11 detects these short fragments in FSHD1 patients, and has therefore been used for diagnostic DNA analysis. However, the reliability of this analysis has been hampered by cross-hybridization of p13E-11 to chromosome 10q26-linked EcoRI fragments of com parable size, which also contain a variable number of 3.3 kb repeated units. Recently, a B lril restriction site was identified within each of the repeated units derived from chromosome 10q26, which enables differentiation of the two polymorphic p13E-11 loci in most cases without haplotype analysis. Remarkably, applying the differential analysis to screen DNA of 160 Dutch cases referred to us for FSHD1 diagnosis, we obtained evidence for subtelomeric exchange of 3.3 kb repeated units between chromosomes 4q35 and 10q26 in affected and unaffected individuals. Subsequently, analysis of 50 unrelated control samples indicated such exchange between chromosomes 4q35 and 10q26 in at least 20% of the population. These subtelomeric rearrangements have generated a novel interchromosomal polymorph ism, which has implications for the specificity and sensitivity of the differential restriction analysis for diagnostic purposes. Moreover, the high frequency of the interchromosomal exchanges of 3.3 kb repeated units suggests that they probably do not contain (part of) the FSHD1 gene, and supports position effect variegation as the most likely mechanism for FSHD1.
INTRODUCTION
Facioscapulohumeral muscular dystrophy (FSHD) is clinically characterized by progressive weakness of the facial, shouldergirdle and upper arm muscles, and in some cases, also the abdominal, foot extensor and pelvic girdle muscles (1,2). The autosomal dominant inherited myopathy shows a variable phenotypic expression with a high penetrance of 95% at the age of 20, and an estimated prevalence of I in 20 000 (1,3).
Linkage analysis assigned the major FSHD locus (FSHD1) to chromosome 4q35 (4,5) distal to D4S139 (6-8). However, genetic heterogeneity was demonstrated for a small number of FSHD families, not linked to 4q35 (9-12). In patients, the FSHD 1 locus on chromosome 4q35 is characterized by a DNA rearrangement within a highly polymorphic EcoRI fragment detectable using probe p l3 E -ll (D4F104S1) (13) . In patients, these FSHD 1-associated rearrangements generate EcoRI frag ments which are shorter than 35 kb (13) (14) (15) (16) (17) , while the size of the 4q35-linked EcoRI fragments in unaffected individuals varies from 35 to 300 kb (13) . Analysis of the p 13E-11 EcoRI fragments of four unrelated FSHD1 patients and controls revealed that the polymorphic fragment contains a variable number of 3.3 kb repeated units (D4Z4), a critical number of which is deleted in patients (18) .
As short EcoRI fragments (<35 kb) linked to 4q35 are associated with FSHD1, probe p l3 E -ll has been used for diagnostic DNA analysis (17) . However, a straightforward analysis is hampered by cross-hybridization of p l3 E -ll to another polymorphic locus which has recently been assigned to *To whom correspondence should be addressed chromosome 10q26 ( 12, 19) . This locus is similarly characterized by EcoRI fragments containing a variable number of 3.3 kb repeated units. The size of these chromosome 10 fragments can be up to 300 kb, but also less than 35 kb in 10% of the population (12,17). Hence, short EcoRI fragments derived from 10q26 may incorrectly be interpreted as chromosome 4q35 deletion frag ments. Haplotype analysis in FSHD families using chromosome 4q35 and 10q26 markers had to be performed to determine the chromosomal origin of a short (<35 kb) pl3E-l 1 fragment (17) . However, due to the presence of small families and isolated cases, only about 50% of short p 13E-11 fragments could unambiguously be assigned to chromosome 4q35, and subsequently used for diagnostic purposes (17) .
Recently, comparative sequence analysis of 3.3 kb repeated units derived from chromosomes 4q35 and 10q26 revealed the specific presence of a Blnl site within each repeated unit from chromosome 10q26. As this restriction site is not present in the repeated units from chromosome 4q35, differential restriction analysis using Blnl enabled direct differentiation of the chromo somal EcoRI fragments without haplotype analysis (19) . By double digestion of genomic DNA with EcoRI and Blnl (or Avril), the pl3E-l 1 EcoRI fragments from 4q35 are reduced in size by 3 kb, while the EcoRI fragments derived from chromo some 10q26 are fragmented completely. This differential restric tion analysis enabled presymptomatic and prenatal diagnosis to be performed with an improved efficiency and reliability, Here, we report the screening of 160 independent Dutch familial or isolated cases referred to us for FSHD1 diagnosis, using the differential restriction analysis. In most cases an unequivocal diagnosis was achieved. Remarkably, a few individuals appeared to be 'monosomie'' or 'trisomie' for the 4q35-linked p 13H-11 fragment. Further analysis of these cases suggested the occurrence of subtelomeric exchanges of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26, generating hybrid EcoRI fragments. As interchromosomal exchanges would have implications for the specificity and sensitivity of the diagnostic DNA testing, the frequency of such events in the population was determined by screening 50 unrelated control DNA samples.
RESULTS

Diagnostic application of differential restriction analysis
EcoRI and EcoRlfBlnl digested DNA of FSHD patients and family members was analyzed by conventional agarose gel electrophoresis and subsequent Southern blot hybridization using probe p l3 E -ll. To illustrate the potency of the differential restriction analysis for diagnostic purposes, the results of family 87 ( 17) are shown in Figure 1 . After EcoRI digestion only, probe p 13E-11 detected a fragment of approximately 30 kb in affected as well as in some unaffected individuals. Haplotype analysis using chromosome 4q35 and 10q26 markers revealed that the 30 kb pl3E-l 1 EcoRI fragment does not cosegregate with either the chromosome 4q35 or 10q26 haplotype (17) (Fig. 1) . However, recently, differential restriction analysis using EcoRI and Blnl indicated heterogeneity of the 30 kb EcoRI fragments. In the affected individuals, the 30 kb EcoRI fragment was reduced in size by 3 kb indicating a chromosome 4 origin (Fig. 1 , haplotype 'A'), whereas in the unaffected individuals the 30 kb EcoRI fragment was completely fragmented, revealing a chromosome 10 origin. The chromosomal origin of the 30 kb EcoRI fragments as suggested by the differential restriction analysis, was confirmed by haplotype analysis performed previ ously (17) . Accordingly, an unequivocal diagnosis was achieved in this family.
In total, 160 independent Dutch familial or isolated FSHD index cases were screened using the differential restriction analysis. In 46 of 160 cases long (>35 kb) EcoRI fragments were observed only. Almost all of these 46 cases were clinically unclear, and referred for exclusion of FSHD1. So far, no unambiguously diagnosed FSHD patient without short EcoRI fragment was observed, which might carry a mutation in the FSHD1 gene itself, or be linked to a second FSHD locus. In 114 of 160 cases, EcoRI digestion revealed a short (<35 kb) p 13E-11 fragment. By double digestion with EcoRI and Blnl, this short fragment was found to originate from chromosome 4 in 102 of 114 cases, indicating a high probability of FSHD1. Short EcoRI fragments completely fragmented by Blnl digestion, were detected in 12 of 114 individuals. Accordingly, these fragments were assumed to originate from chromosome 10q26, suggesting a lowered probability of FSHD1. However, at least three 4q35-linked familial and three isolated cases carrying such short, apparently chromosome 10q26 derived, EcoRI fragments, were clinically unambiguously diagnosed with FSHD (GWP). Al though differential restriction analysis and clinical diagnosis implied that these cases either contain a mutation in the FSHD1 gene itself or are linked to a second FSHD locus, further analysis suggested another explanation (see below).
Subtelomeric exchange of repeated units
In applying the differential restriction analysis we observed several FSHD index cases and unaffected spouses which appeared to be either 'monosomic' or 'trisomic' for the pl3E-11 fragment on chromosome 4q35. To demonstrate such aberrant Blnl restriction patterns, a very interesting family (family 28, Fig.  2a ) was selected. In this family, a 25 kb EcoRI fragment was detected which cosegregates with FSHD 1 and which was reduced in size by 3 kb after Blnl digestion (Fig. 2b) . Therefore, a clear diagnosis was achieved. Remarkably, the father (individual 28.1) who is asymptomatic, also carries a second short Z?//xI-resistant EcoRI fragment (22 kb). As the father is transmitting both his chromosomes 4 and both his chromosomes 10 whereas the 22 kb fragment is not inherited by any of his children (Fig. 2a) , he is considered somatic mosaic for this 22 kb fragment. In addition, the father strikingly showed two other £//zI-resistant, 4q35-like fragments. In his offspring, three 5/nI-resistant EcoRI fragments were also detected in sons 28.4 and 28.5, while one BlnI-resistant EcoRI fragment only was observed in the youngest son 28.6. Moreover, the unaffected mother (individual 28.2) also shows one 5//7l-resistant EcoRI fragment only. Pulsed-field gel electro phoresis was performed (Fig. 2b) , which confirmed the apparent 'mono-and trisomy' observed by conventional gel electrophore sis. We hypothesized that an exchange of 3.3 kb repeated units between chromosomes 4q35 and 10q26 might have occurred, generating hybrid p 13E-11 fragments (Fig. 3) . In cases 28.1,28.4 and 28.5, one of the chromosome 10q26 fragments contain repeated units without Blnl sites, probably derived from chromo some 4q35. In cases 28.2 and 28.6 one of the chromosome 4q35 fragments contains 10q26-like repeated units including Blnl sites. .: , -i ; 'A ' y : fím^á^:ri;é K y: :
' . ' S .
/ , : --y its
■ * : r r /.
•
7 . . •
• . -VS . -, ' : V,.
• , .i. » r r i
■yy'<r>Yp' ' ■ > ' I .
• •» fe 
